CITADEL ADVISORS LLC
Q4 2023 13F-HR Holdings
Net value change ($000)
+33,820,573
(7.2%)
New positions
1100
Sold out positions
1049
Turnover %
6.9%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SPY | 1,591,592 | 153.9% |
| NVDA | 905,733 | 101.4% |
| AMZN | 703,862 | 290.8% |
| AMD | 628,379 | 244.6% |
| DIS | 578,484 | 1096.5% |
| META | 544,657 | 167.9% |
| T | 532,631 | 166.8% |
| MCD | 450,792 | 550.7% |
| SPGI | 441,196 | 2362.0% |
| DT | 434,594 | 123464.2% |
Top Reduces (Value $000, Stocks/ETFs)
| AIY | -1,406,476 | -100.0% |
| CMCSA | -681,123 | -98.6% |
| BSX | -597,827 | -53.5% |
| PANW | -562,915 | -99.9% |
| TMUS | -543,867 | -96.6% |
| Seagen Inc. | -515,189 | -100.0% |
| Horizon Therapeutics Public Ltd Co | -480,093 | -100.0% |
| ADBE | -451,187 | -74.3% |
| HD | -399,137 | -67.5% |
| ABBV | -383,956 | -82.4% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
400,971,805
(80.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|